Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 12, Issue 12, pp. 849-860
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 11, 2019
- Revision received August 10, 2019
- Accepted September 20, 2019
- Published first September 25, 2019.
Article Versions
- Previous version (September 25, 2019 - 07:30).
- Previous version (November 15, 2019 - 06:29).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Feifei Liu1,
- Xueyin Zu1,2,
- Xiaomeng Xie1,2,
- Yuanyuan Zhang1,2,
- Kangdong Liu1,2,3,4,
- Hanyong Chen5,
- Ting Wang1,2,
- Ann M. Bode5,
- Zigang Dong5,*, and
- Dong Joon Kim1,2,4,*
- 1China-US (Henan) Hormel Cancer Institute, Henan, China.
- 2The Pathophysiology Department, The School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
- 3The Affiliated Cancer Hospital, Zhengzhou University, Zhengzhou, Henan, China.
- 4The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention, Zhengzhou, Henan, China.
- 5The Hormel Institute, University of Minnesota, Austin, Minnesota.
- ↵*Corresponding Authors:
Dong Joon Kim, China-US (Henan) Hormel Cancer Institute, No, 127 Dongming Road, Zhengzhou, Henan 450008, China. Phone: 156-1790-7639; Fax: 371-6558-7227; E-mail: djkim{at}hci-cn.org; and Zigang Dong, The Hormel Institute, University of Minnesota, 801 16th Avenue NE, Austin, MN 55912. Phone: 150-7437-9600; Fax: 150-7437-9606; E-mail: zgdong{at}hi.umn.edu
December 2019
Volume 12, Issue 12
Volume 12, Issue 12
Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma
Jump to section
Advertisement